Daniela Meco
Rome, 00168, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers.
Journal: International journal of molecular sciences
Published: December 13, 2022
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models.
Journal: International journal of molecular sciences
Published: January 02, 2021
hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF.
Journal: Pathology oncology research : POR
Published: September 30, 2020
Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells.
Journal: Oncology reports
Published: May 13, 2020
Ectopic nerve growth factor prevents proliferation in glioma cells by senescence induction.
Journal: Journal of cellular physiology
Published: August 13, 2018
Novel SEC61G-EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens.
Journal: Cancer research
Published: March 17, 2017
Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models.
Journal: Neuro-oncology
Published: February 15, 2014
Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.
Journal: Cancer chemotherapy and pharmacology
Published: June 13, 2012
The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects.
Journal: Biochemical pharmacology
Published: January 13, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026